This Experimental Drug Just Received Orphan Drug Designation For Congenital Adrenal Hyperplasia
According to a story from prnewswire.com, the experimental treatment SPR001 was just granted orphan drug status by the Food and Drug Administration (FDA). The new treatment is currently being developed…